Rush University Medical Center
As one of the leading neurology and neurosurgery institutions in the
United States, Rush University Medical Center’s Department of
Neurological Sciences is involved in important and leading research in
Alzheimer’s disease and neuromuscular disease.
FHL’s current pipeline of drug candidates is the result of research and initial
development undertaken at Rush.
Platform Partners
and Development
Collaboration
As an open development platform,
we actively welcome engagement with partners at all stages of development
from licensing-in of potential therapeutic candidates to partnerships related to
co-development of FHL candidates as well as license-out arrangements.